Neuromonics Pty Ltd is a specialist healthcare company dedicated to providing treatment for the medical condition of tinnitus.
Neuromonics is committed to improving the choice and quality of treatments available for people with tinnitus and associated tinnitus disturbance. We employ clinicians experienced in the field of auditory problems who specialise in the treatment of tinnitus disturbance.
Founded in 2001 and backed by venture capital investors, the company has developed a global breakthrough in tinnitus treatment. The Neuromonic Tinnitus Treatment was discovered and developed at Western Australia's Curtin University of Technology by Dr Paul Davis, Adjunct Associate Professor. It's development over a period of more than ten years has involved extensive refinement through research and clinical trials.
Backed by Australian and international patents, Neuromonics Tinnitus Treatment is now available across Australia and through a number of well respected clinics in the United States. Expansion plans are underway to make it more widely available in the United States in 2006 and Europe in 2007.